PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.33%
Revenue growth under 50% of NXPI's 3.21%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
-1.92%
Negative gross profit growth while NXPI is at 0.13%. Joel Greenblatt would examine cost competitiveness or demand decline.
-542.50%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-231.58%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-293.42%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-274.42%
Both companies exhibit negative EPS growth. Martin Whitman would consider sector-wide issues or an unsustainable business environment.
-274.42%
Both face negative diluted EPS growth. Martin Whitman would suspect an industry or cyclical slump with heightened share issuance across the board.
0.10%
Slight or no buybacks while NXPI is reducing shares. John Neff might see a missed opportunity if the company’s stock is cheap.
-2.51%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
2.32%
Dividend growth above 1.5x NXPI's 0.12%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-7.27%
Negative OCF growth while NXPI is at 37.88%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-52.53%
Negative FCF growth while NXPI is at 94.26%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
53.71%
10Y revenue/share CAGR at 50-75% of NXPI's 79.10%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
11.08%
5Y revenue/share CAGR under 50% of NXPI's 77.31%. Michael Burry would suspect a significant competitive gap or product weakness.
3.47%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
No Data
No Data available this quarter, please select a different quarter.
12095.78%
5Y OCF/share CAGR above 1.5x NXPI's 107.18%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
-44.04%
Both face negative short-term OCF/share growth. Martin Whitman would suspect macro or cyclical issues hitting them both.
-937.41%
Negative 10Y net income/share CAGR while NXPI is at 36.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-1.99%
Negative 5Y net income/share CAGR while NXPI is 328.95%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-193.53%
Both companies show negative 3Y net income/share growth. Martin Whitman suspects macro or sector-specific headwinds in the short run.
No Data
No Data available this quarter, please select a different quarter.
50.55%
5Y equity/share CAGR above 1.5x NXPI's 18.89%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
66.64%
3Y equity/share CAGR above 1.5x NXPI's 42.98%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
108.73%
Dividend/share CAGR of 108.73% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
-69.20%
Negative 5Y dividend/share CAGR while NXPI stands at 169.49%. Joel Greenblatt sees a weaker commitment to dividends vs. a competitor that might be growing them.
33.29%
3Y dividend/share CAGR above 1.5x NXPI's 20.43%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
10.02%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
-13.16%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
3.42%
Asset growth above 1.5x NXPI's 0.28%. David Dodd checks if M&A or new capacity expansions are value-accretive vs. competitor's approach.
-3.93%
We have a declining book value while NXPI shows 3.20%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
44.26%
We have some new debt while NXPI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
90.64%
R&D growth drastically higher vs. NXPI's 4.75%. Michael Burry fears near-term margin erosion unless breakthroughs are imminent.
-2.24%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.